Company Information
- Type:
- Company
- Country:
- United States of America
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 05 May 2017 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Financial Information
Engagements
Affiliated Subsidiaries
| Country | Company Name |
|---|---|
| India | Mylan Laboratories Ltd |
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 10-Jul-2024 | 2024 Communication on Progress | Submitted |
| 21-Feb-2024 | 2023 Communication on Progress | Submitted |
| 09-May-2022 | Viatris 2021 Sustainability Report (UNGC CoP) | Active |
| 06-May-2021 | Viatris 2020 Sustainability Report | Active |
| 04-May-2020 | Mylan’s 2019 Global Social Responsibility Report | Active |
| 04-Apr-2019 | Mylan 2018 Global Social Responsibility Progress Report | Active |
| 05-May-2018 | Mylan 2017 Progress Report on Global Social Responsibility | Active |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.